Alyssum Therapeutics
Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
1
Funding Rounds
$26.0m
Money raised
Funding series
Funding Series Analysis
The company Alyssum Therapeutics has raised a total of $26m in funding over 1 rounds.
Key Insights:
- Alyssum Therapeutics October 2024 Series A Funding Round: $26m
Alyssum Therapeutics October 2024 Series A Funding Round
$26m
Industries
Alyssum Therapeutics is active in the following industries: